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iThe EU 7th Framework Programme for Research and Technological Development funded 
Marine Biotechnology ERA-NET (ERA-MBT), prepared a roadmap for future marine 
biotechnology research and innovation.
The preparatory work to the roadmap involved partners in the ERA-MBT project conducting desk 
studies, on-line questionnaires, interviews, stakeholder workshops, a foresight-like study and 
extensive engagement with an advisory group of international experts (Appendix 1). A goal of ERA-
MBT is to support the development of marine biotechnology research and innovation, enabling 
its growth within a self-sustained enterprise driven network. 
The EU Blue Growth strategy embeds marine biotechnology in the Bioeconomy Strategy for 
Europe recognising its role in helping to meet the societal and other challenges faced by Europe. 
In developing this roadmap, ERA-MBT identified an optimistic future for marine biotechnology; 
one closely aligned with the sustainable utilisation of marine bioresources in ways that establish 
new markets, generates revenue and increases employment. 
Exploring the potential of marine biodiversity has increased, indicating it to be a rich source of novel 
natural compounds. Some of these compounds are already used in food, cosmetic, agricultural, 
chemical and pharmaceutical products, but their diversity has not been fully characterised and 
utilised. Further opportunities exist for the use of ocean bioresources in markets for industrial 
enzymes, functional foods, cosmeceuticals, biomaterials, bioprocessing and medical devices. 
The ERA-MBT research and innovation roadmap highlights research and innovation as spanning 
scientific, technological, economic and societal challenges and in doing so, sets a marine biotechnology 
research and innovation agenda to 2030. The roadmap identifies five thematic areas; the first three 
enable the exploration of the marine environment; support biomass production and processing; and 
contribute to product innovation and differentiation; whilst the remaining two, policy support and 
stimulation; and the provision of enabling technologies and infrastructure; provide the essential 
foundation to support growth in the bioeconomy.
EXECUTI V E 
SUMM A RY
i i
EXPLORATION OF THE MARINE ENVIRONMENT
Exploring the chemical and biological diversity of our oceans as a source of novel materials and 
food is the essence of this strategic research area. Despite the promise of the oceans, the technical 
challenges of accessing areas outside the shallow coastal zone, and the costs of deepwater 
exploration, mean much of the oceans’ depths remain to be discovered. The provision of a pipeline 
of new organisms to screen for novel compounds is an essential support for future innovation.
BIOMASS PRODUCTION AND PROCESSING
The main sources of marine biomass are species harvested from the wild and those that can be 
cultured. Securing sustainable marine biomass presents challenges, particularly if the sole source 
is from wild stocks, where overexploitation can threaten marine biodiversity as well as future 
supply of the target species. The strategic management of wild species coupled with plans to 
deliver more coherent and effective species management are essential if wild stocks are to remain 
viable sources of biomass and ecosystem health and services are to be maintained. Consistency, 
security and quality of biomass supply have to be balanced in ways that address environmental 
challenges and demands for sustainability. The well-managed and controlled culture of marine 
biomass, whilst similarly facing production challenges, offers sustainable sources of biomass.
PRODUCT INNOVATION AND DIFFERENTIATION
Emerging opportunity areas and completely novel applications for marine-derived compounds 
exist. The health sector, which targeted marine-derived molecules as new pharmaceutical entities, 
continues to emphasise the potential of marine origin materials in drug discovery. Target markets 
for marine origin lipids, proteins including enzymes, pigments, and flavours include human and 
animal nutrition, industrial chemicals, cosmetics, pharmaceuticals, personal care, the agri-food 
sector and many more. 
ENABLING TECHNOLOGIES AND INFRASTRUCTURE
Despite the progress enabled by EU programmes, there remains an acute need to continue to 
create research and innovation capacity in both the research and enterprise sectors. Doing so will 
enhance the scientific and technological research infrastructures, thereby providing access to an 
array of new research support “tools” and facilities to support marine biotechnology. Many of the 
tools and techniques used in marine biotechnology are widely used in other areas of science and 
technology. Engaging in collaborative research projects is one way of providing access to these 
facilities and encouraging multi-disciplinary research. A challenge faced by marine biotechnology 
researchers is to align their discovery and development activities with the needs of target markets. 
Establishing a link between researchers and the array of end-users is essential in stimulating 
innovation. Though there are strong links between the marine biotechnology research community 
and areas of fundamental and applied sciences, the need for dedicated research tools and facilities 
to fully exploit marine biological resources remains. 
E X EC U T I V E SU M M A RY 
i i i
POLICY SUPPORT AND STIMUL ATION
The ubiquitous nature of marine biotechnology results in the research and innovation activities being 
shaped by a wide range of European and international policy instruments and regulations. Policy 
links exist between the environment, fisheries and aquaculture, food, health, natural resources and 
industrial sectors, which both highlight the expectations for marine biotechnology and stimulate 
activity. Research activities also generate knowledge that informs and influences policy. Knowledge 
derived from marine biotechnology research contributes to how the marine environment can be 
managed sustainably and fulfil its role in providing environmental services to the planet. It can 
contribute to ocean governance and to the development of regulations concerning the use of 
ocean resources. Strong supportive policies are fundamental to the creation of successful marine 
biotechnology activity; importantly, they create the environment for the sustainable exploitation 
of marine bioresources. National and European policies and strategies determine the extent to 
which funding and other initiatives can stimulate companies to engage in marine biotechnology 
related research and innovation.
The marine biotechnology research and innovation roadmap proposes a series of short- and long-
term actions in each thematic area. Individual actions are those that offer the greatest potential to 
deliver economic and societal returns and to where future funding and other supporting initiatives 
should be directed. These are summarised in Table 1. 
iv
SHORT-TERM ACTIONS  
2016 –2020
LONG-TERM ACTIONS  
2020–2030
Exploration 
of the marine 
 environment
Continue to target traditional sources of 
marine biomass, including samples held in 
repositories; maximise the use of available 
methods to identify species, and to isolate, 
characterise and assess compounds from 
marine organism for bioactivity. 
Explore targeted environments and hot-
spots; develop next generation sampling 
methods; and develop novel methods for 
the taxonomic, chemical, and biochemical 
evaluation of marine species as sources of 
bioactive compounds.
Biomass 
 production and 
pro cessing
Develop processes to support the harvesting 
and culture of available biomass and refining 
methods for the production of food, feed and 
other non-food related products. 
Establish integrated processing of mixed 
feedstock and the optimised culture 
of  species for food use and as novel 
 compounds, while sustaining the health 
of cultured species.
Product 
 innovation and 
 differentiation 
Expand the range of functional foods/
ingredients, nutraceuticals, cosmeceuticals, 
fine chemicals, enzymes and other biomaterials 
derived from marine organisms and also 
explore their use in sensors and as biological 
indicators.
Develop a new generation of therapeutics 
and other biocompatible materials 
obtained from marine organisms; develop 
new concepts of bioremediation and novel 
processes based on marine organisms and 
compounds. 
Enabling tech-
nologies and 
infrastructure
Maximise the role of national research 
networks in forming new collaborations 
to support marine biotechnology research 
activities; expand the range of available 
analysis and assessment tools and 
methodologies; continue to map marine 
habitats and biodiversity. 
Continue to build research networks and 
international collaborations to expand 
marine biotechnology research activity. 
Strengthen marine biotechnology 
research and innovation by developing 
new tools and approaches to find 
biological and environmental hotspots, 
and characterise the bioactive potential of 
marine compounds. Create pilot facilities, 
materials repositories and related datasets. 
Policy support 
and stimulation
Implement national agreements on access 
to marine habitats and environmental 
regulations concerning the harvesting of 
marine organisms. Expand the provision of 
national and EU funds to generate knowledge 
about marine organisms, which is required 
to develop an expanded range of marine 
biotechnology enabled products. 
Implement global agreements on access 
to resources and access beyond national 
jurisdictions. Introduce common licensing 
systems concerning the access to and use of 
marine organisms.  Encourage the creation 
of dedicated Venture Capital funds for 
businesses based on marine biotechnology 
research. Establish marine biotechnology 
targeted public/private partnerships. 
TABLE 1  A summary of short- and long-term actions in each thematic area that offer the greatest potential   
    to deliver economic and societal returns.
vGovernments around the world are seeking opportunities for sustainable economic 
growth, recognising that economic success cannot come at further cost to the planet’s 
threatened ecosystems. Many of the most exciting opportunities are found in what is 
termed the "bioeconomy", where the application of biotechnology to biomass, is delivering 
new products and services for population health, sustainable industries and primary 
production. Today’s bioeconomy is advancing faster and showing greater promise than 
ever before, driven by both scientific advances and markets demanding sustainable 
solutions to today’s global grand challenges of food and fuel security, sustainable 
industry and population health.
As demands on the bioeconomy increase, there is a pressing need to find new, sustainable sources 
of biomass to meet demand. The marine environment harbours one such source, and one that 
remains largely underutilised, so far exploited largely by capture fisheries oriented toward human 
consumption of fish and related ingredients. However, unsustainable harvesting of wild stocks has 
led to a decline of some species, and although conservation and improved resource management 
have allowed some species to recover, the scope to increase production from the wild is limited and 
more efficient use of existing resources is necessary. Over the last 40 years, commercial aquaculture 
and mariculture have demonstrated the potential for greater marine biomass production, creating 
new biomaterial supply-chains for selected marine organisms. Marine biotechnology is the key to 
unlocking the value of marine biological resources, providing biobased and other industries with 
access to sustainably produced and renewable biomass. Marine bioresources found in some of the 
most extreme and unique ecosystems on the planet, are rich sources of novel materials and bioactive 
compounds that can help to meet the demand for improved health and wellbeing, and support a 
wide range of other consumer and industrial applications. Whilst recent attention is directed to 
the greater utilisation of algae for products other than food, the diversity of marine organisms 
(including micro-organisms) make them highly attractive in a broad range of other applications. 
Marine biotechnology is a critical component of today’s bioeconomy, enabling marine biomass to 
be cultivated, harvested and processed to support the production of innovative products, stimulate 
new industrial activity, and support existing industry to become more competitive. Now is the time 
to broaden and diversify our research efforts; moving from a well-established demonstration of 
the merits of biotechnology applied to marine biomass, to a broad range of products meeting 
market demands sustainably.
PREFACE
v i
The marine biotechnology roadmap produced by the ERA-MBT project provides a framework for 
future marine biotechnology research and innovation activities creating new biomaterial supply 
chains. It also identifies the dependence of future marine biotechnology activity on contributions 
from a wide range of scientific and technological disciplines, and from existing European policy 
shaping marine biotechnology research and innovation in the “Blue Growth” strategy. The view 
of the ERA-MBT International Advisory Group is that this roadmap provides a practical and 
realistic approach by which marine bioresources and biotechnology can contribute to economic 
and societal progress.
Dr Rachael Ritchie, Genome British Columbia, Canada 
Chair of the ERA-MBT International Advisory Group
ERA-MBT is grateful for the support and encouragement of members of the ERA-MBT International 
Advisory Group — Dr. Fernando de la Calle, Prof. Alan Dobson, Dr. Fredrika Gullfot, Prof. Frank 
Oliver Glöckner, Prof. Adrianna Ianora, Dr. Ernst Kloosterman, Ms. Nathalie Moll, Dr. Rachael 
Ritchie, Prof. Patrick Sorgeloos, Dr. Helena Vieira and Prof. Uwe Waller over the course of this 
project, and appreciates the contribution of the International Advisory Group in defining the 
marine biotechnology roadmap.
This roadmap  is made possible through the help and support from consortium partners and the 
wider scientific, policy and industrial community who generously contributed to this document 
and to the ERA-MBT Foresight process.
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1Research and innovation are behind the use of 
marine origin compounds in new product and 
process development, helping firms to create 
novel pharmaceuticals, food products, functional 
ingredients and nutraceuticals, medical and other 
diagnostic devices. In addition to these health 
applications, marine-derived compounds are used as 
novel industrial materials — composites, biopolymers, 
and enzymes in different industries2. The long 
established use of algal components in animal and 
plant health applications is expanding with new 
markets for the use of algae in feed, personal care 
and cosmeceuticals. Other areas where marine 
biotechnology underpins future growth include the 
remediation and management of environments, 
and in aquaculture, in particular, breeding, feed, 
and health. The successful performance of marine 
biotechnology in delivering products that contribute 
to meeting the global challenges of food supply, 
improved health for all and stimulating the growth 
INTRODUCTION
and sustainability of industries is beginning to drive 
further product and process innovation. 
Opportunities exist for marine biotechnology to 
continue to support activities directed towards 
securing greater value from marine organisms. The 
increase in marine biodiscovery related activity is 
likely to expand the range and availability of novel 
marine origin materials. The reported research 
and innovation successes to date emphasise 
contributions from traditional sources of biomass 
such as algae, fish and shellfish in developing food 
products and food ingredients with physical-chemical 
functional properties. There are also early signs that 
further successes in health applications, particularly 
new pharmaceuticals, derived from sponges and 
other marine invertebrates, algae, fungi and marine 
microorganisms are possible3.
With plans to continue to develop the European bioeconomy, contributions from marine 
biotechnology research and innovation will help firms in different industry sectors to diversify 
their products. Marine biotechnology enables the production and use of marine biomass. The 
definition of marine biotechnology as used in this roadmap builds on that provided by the 
OECD1 in its general definition of biotechnology:  
“The application of science and technology to living organisms from marine resources, as well as 
to parts, products and models thereof, to alter living and non-living materials for the production 
of knowledge, goods and services.”
2New, more sustainable processes are required to 
transform marine biomass into products. Some 
enzymes, drugs, nutrients, fine chemicals and other 
products are produced using specially designed 
organisms and processes. The knowledge and 
expertise developed in this area may be useful in 
creating new approaches to processing marine 
biomass.
Activities of the Marine Biotechnology ERA-NET 
(ERA-MBT) are designed to support Europe’s 
goals to create a lasting bioeconomy. In doing so, 
ERA-MBT works with stakeholders across Europe 
to identify future biotechnological needs and to 
support opportunities that maximise the use of 
marine bioresources. The approach of ERA-MBT 
is to enhance all elements of the value chain, from 
research and development, to supporting proof of 
The vision for marine biotechnology as defined by ERA-MBT is: To support Europe’s marine 
biotechnology community to participate in a lasting, enterprise-driven network that adds value 
to marine biological resources in ways that nurture and sustain the lives of European citizens.
I N T RODUC T ION
concept and stimulating the uptake of research 
outputs by industry, and thereby contribute to 
the development of the European bioeconomy. A 
description of the ERA-MBT roadmap process and 
insights to the objectives of ERA-MBT are given in 
Appendix 1 and Appendix 2 respectively. 
In seeking to create a lasting network of funding 
for marine biotechnology, the ERA-MBT project 
developed this strategic research and innovation 
roadmap to highlight future marine biotechnology 
related activities. This provides a framework on 
which to continue to develop research competences 
and support the development of the European 
bioeconomy while addressing the societal challenges 
of health, demographic change and wellbeing; food 
security; and the supply of raw materials.
3

M A RINE 
BIOTECHNOLOGY 
A ND THE 
BIOECONOMY
CHAPTER 01
“The application of marine biotechnology is essential 
for the sustainable development of aquaculture.”
PE T T E R A R N E SE N  — BR EEDI NG DI R EC TOR , M A R I N E H A RV E ST A S A
6MARINE BIOTECHNOLOGY —  
AN ENABLING TECHNOLOGY
Marine biotechnology is a key enabling technology 
that supports the development of the bioeconomy. 
It is a multi-disciplinary, knowledge and capital-
intensive technology that is relevant throughout 
the value-chain and spans different sectors as 
illustrated below in Figure 1. In doing so, it provides 
new opportunities for industry to further develop 
significant competitive advantage, stimulate growth 
and create new jobs by exploiting the potential of 
marine biological organisms.
MARINE BIOMASS
Oceans and seas comprise upwards of 70 percent 
of the surface of our planet and are home to 90 
percent of Earth’s biosphere4. Marine biomass 
originates from the extensive marine biodiversity of 
the oceans and comprises many forms, including e.g. 
whole fish, discards from wild harvest or processing, 
aquaculture products, macro-algae — both wild 
and cultivated, micro-algae, marine invertebrates 
and marine micro-organisms. The production and 
processing of marine biomass include both individual 
marine species and biomass that comprises multiple 
species. The starting point or input to the process 
of extracting value from marine bioresources is the 
culture and harvesting of available marine biomass. 
“Marine biotechnology is a 
key enabling technology that 
 supports the development of 
the bioeconomy.”
FIGURE 1  The contribution of marine biotechnology to global markets
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Whether the desired end-result is a compound for a 
new pharmaceutical, a novel enzyme, food ingredient 
or biomaterial — marine biomass is transformed. 
ROLE OF BIOSCIENCES
The marine ecosystem comprises many environmental 
niches that are home to a large number of organisms 
across many trophic layers. Because these species 
have evolved to live in diverse environments with 
variations in salinity, nutrients, temperature, light 
and pressure, they are a source of chemical and 
biochemical diversity with potential applications 
in novel products and processes. 
The rapid and extensive scale of scientific and 
technological developments within the biosciences 
has significantly improved our knowledge of marine 
biological resources. These new developments include 
next-generation gene sequencing, bioinformatics, 
post-genomics, functional genomics, transcriptomics, 
proteomics, protein structures, metabolomics.  In 
addition, new chemical methods that characterise 
the complex chemistry, and assays to assess the 
bioactivity of marine origin compounds support the 
search for novel biomaterials, proteins, and safe, 
sustainable and healthy food.
CONTRIBUTION TO THE BIOECONOMY
The EC describes Europe’s bioeconomy as “those 
parts of the economy that use renewable biological 
resources from land and sea — such as crops, forests, 
fish, animals and micro-organisms — to produce 
food, materials and energy”5. The development of 
Europe’s bioeconomy is focused on the conversion 
of renewable resources from terrestrial and marine 
environments into food, animal feed and related 
bio-based products and is recognised as helping to 
meet Europe’s grand challenges for the 21st century6. 
“Scientific and  technological 
de velopments within the 
 bio sciences has significantly 
 improved our knowledge of 
 marine biological resources.”
8Europe’s Blue Growth Strategy, which describes 
"...opportunities for marine and maritime sustainable 
growth" was published in 20127. It contains five 
distinct high-growth areas of which marine 
biotechnology, termed “blue biotechnology”, is 
one. Blue Growth is embedded in the overarching 
 “Bioeconomy Strategy for Europe” adopted by the EC. 
There is a long-standing and persistent reference 
to the scope of marine biotechnology within policy 
and research communities, which highlights the 
opportunity for “blue biotechnology” to contribute 
to meeting Europe’s societal and other challenges. 
The Standing Committee on Agricultural Research 
(SCAR) in their 4th Foresight Exercise8 published 
in October 2015 identified how marine resources 
could contribute to the European bioeconomy. 
Although the current volumes of marine biomass 
are relatively minor compared to terrestrial biomass, 
the potential for converting marine biomass into 
valuable products is high and seen as supporting 
a sustainable bioeconomy. 
INDUSTRY ACTIVIT Y AND GLOBAL 
 MARKETS FOR OCEAN BIORESOURCES
Major opportunities exist to extend the use of ocean 
bioresources in markets for industrial enzymes, 
pharmaceuticals, functional foods, cosmetics 
and agricultural products. Further, there are fast 
emerging applications in new end-use areas including 
bioprocessing, environmental remediation and 
monitoring, chemicals, cosmeceuticals, biomaterials 
and in medical devices: whilst the global population 
growth continues to fuel the demand for food 
products from the oceans and seas.
Several estimates of the market value for marine 
biotechnology enabled products exist; however, 
these vary depending on which market segments 
are included. The report for DG Maritime Affairs and 
Fisheries "Study in support of Impact Assessment 
“Major opportunities exist 
to extend the use of ocean 
 b iores ources  in  markets 
f o r  i n d u s t r i a l  e n z y m e s , 
pharmaceuticals, functional 
foods, cosmetics and agricultural 
products.”
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work on Blue Biotechnology"9 projected revenue from 
blue biotechnology could reach €1 billion within 5 
years if a market growth of 6-8% per annum was 
maintained, and result in the creation of 10,000 
new jobs.
A 2015 market report from market analysts Smithers 
Rapra "The future of marine biotechnology for 
industrial applications to 2025"10 indicates the global 
market for marine biotechnology has the  potential 
to reach $4.8 billion by 2020, rising to $6.4 billion 
by 2025. This report identifies new applications for 
marine-derived enzymes and the use of marine 
algae and micro-algae in biofuel production as 
key drivers of the market growth. On the back of 
extensive aquaculture activity, including culturing 
macro-algae for hydrocolloids, the Asia-Pacific 
market is described as the fastest growing one. 
Europe is recognised as a high-potential region 
for future growth resulting from an extensive, yet 
largely unexplored marine resource. Many firms 
using materials produced by marine biotechnologies 
are from industry sectors not generally recognised 
as part of the marine sector. 
Levels of research activity involving marine natural 
products were described in a 2009 analysis of patent 
activity, which reported marine resources being 
used in five application domains — food, cosmetics, 
agriculture, chemistry and pharmacology11. There 
are also reports of increased patent activity in 
these sectors over the period 1973 to 2007, with 
patents from the chemical and pharmacology sector 
increasing by 53.5 and 32.2 percent  respectively12.
The involvement of biotechnology in exploring the 
potential of marine biodiversity has increased, 
resulting in the widespread recognition that the 
biodiversity of the marine environment is now a 
rich source of natural compounds. Research driven 
advances in marine biotechnology are responsible 
for many successes in areas of human health 
and wellbeing and in how marine environments 
are managed. Potent natural products obtained 
from marine organisms continue to demonstrate 
many bioactivities including anti-tumour, anti-
inflammatory, analgesia, immunomodulation, allergy, 
and anti-viral properties13. The pharmaceutical 
industry was early in recognising the potential 
of marine biodiversity as the basis for new drugs 
with more than 1,000 novel marine chemicals in 
preclinical trials between 1998 and 201114. Against 
a background of lengthy development timescales 
for new therapeutic compounds, as of December 
2015, seven FDA approved marine origin drugs were 
in clinical use and a further 28 at various stages of 
clinical trials15. Fish, sponges, tunicates, molluscs 
and bacteria are the main sources of compounds 
in these trials. 
By 2018 the global market for nutraceutical products 
is expected to be worth $250 billion16. This market 
includes products described as food or nutritional 
supplements, functional foods, special dietary foods, 
sports drinks and medically formulated foods. The 
market for Omega 3 polyunsaturated fatty acid is 
projected to grow at nearly 14 percent per annum 
and reach close to $19 billion by 202017. Industry 
sources estimate marine products comprise 32% 
of the nutraceuticals market18.
The market for cosmeceuticals has emerged 
as the fastest growing segment of the global 
cosmetics industry. These products are relatively 
recent additions to the cosmetics and personal 
“The global market for marine 
biotechnology has the potential 
to reach $4.8 billion by 2020, 
rising to $6.4 billion by 2025.”
10
care markets, providing therapeutic like benefits 
to users. The global market for cosmeceutical 
products was estimated as $30.5 billion in 2010 
and set to rise at a rapid pace; growing at a rate 
of around 9% per annum between 2015 and 202019. 
Marine compounds have a long history of use in the 
cosmetics sector20.
Consumer demand for products based on 
natural materials contributes to growth in the 
cosmetics and cosmeceuticals markets. Whilst 
terrestrial plant extracts remain a major source 
of natural ingredients, marine origin ingredients 
have emerged as an alternative21. Compounds 
derived from salmon eggs, micro- and macro-algae, 
fish skins, and plants found in coastal regions 
are processed by specialist ingredient suppliers 
and supplied to manufactures of cosmetic and 
cosmeceutical products. A further industry study 
“The projected high-growth 
opportunities for health, food 
and biomaterials-related 
applications offer considerable 
scope to create high-value 
p r o d u c t s  f r o m  m a r i n e 
bioresources.”
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points to 13% of the global cosmetics market being 
products that incorporate marine ingredients22. 
The projected high-growth opportunities for health, 
food and biomaterials-related applications offer 
considerable scope to create high-value products 
from marine bioresources. Residues remaining 
following the extraction of high-value compounds 
from marine bioresources are a source of biomass 
with energy use potential. 
POLICY
Marine biotechnology related research and innovation 
is recognised by policy makers and the enterprise 
sector as offering significant potential to fill market 
gaps for new products, processes and services. 
The challenge of developing marine biotechnology 
capabilities has already been embraced by EU 
member states and some have developed plans 
to improve their bioeconomy by increasing the use 
of aquatic resources23. There are also examples of 
national research strategies developing a sustainable 
bioeconomy on the back of marine biotechnology 
research and innovation activities24,25. Previous and 
current European research funds target unexplored 
and underexploited marine resources as a source 
of high-value products.
PROGRAMMES, INITIATIVES  
AND PROJECTS
Before the advent of the EU's 6th Framework 
Programme for Research and Technological 
Development (FP6), marine biotechnology 
contributed to projects where the main aim was 
basic research, food or feed production, health etc. 
In the follow-on research programme, FP7, call topics 
specifically targeting marine biotechnology were 
included in the "Oceans of Tomorrow" initiative26. 
Europe’s current research programme Horizon 
2020, includes several marine biotechnology related 
research themes/topics.
Europe’s Blue Growth Strategy describes 
 "…opportunities for marine and maritime sustainable 
growth", in which the development of marine 
biotechnology activities is set to grow incrementally 
as below. 
• Firstly, in the short-term as a niche market 
development focused on high-value products for 
the health, cosmetic and industrial biomaterial 
sectors, 
• A second stage up to 2020 in which markets 
expand with the production of metabolites and 
primary compounds as input for the food, feed 
and chemical industries, and finally 
• Some 15 years later where the sector becomes 
a provider of mass-market products, together 
with a range of high added-value specialised 
products.
The Blue Growth Strategy emphasises the 
importance of marine bio-based products as 
alternative sources of carbon and energy, with 
specific reference to the role of renewable resources 
such as micro-algae. This challenge was taken 
up the Bio-based Industry Consortium in a Joint 
Undertaking with the European Commission as 
part of an Institutional Public Private Partnership, 
which launched a call in 2015 for research projects to 
reduce the costs of bioprocessing algae by applying 
a multi-stream biorefining concept27. The need to 
enhance the bioprocessing of marine biomass was 
also the theme of a call for research proposals 
(biorefining), by ERA-MBT in 2015, resulting in the 
provision of €8.5 million to support six transnational, 
joint research projects.
ADDRESSING SOCIETAL CHALLENGES — 
A ROLE FOR MARINE BIOTECHNOLOGY
With a focus on supporting research needed to 
meet Europe’s Societal Challenges, the Horizon 2020 
research programme is fundamentally different to 
the earlier research framework programs. Marine 
biotechnology is relevant to major challenges in 
Horizon 2020,28 in particular, health, demographic 
change and wellbeing; food security, sustainable 
1 2
agriculture and forestry, marine and maritime 
and inland water research and the bioeconomy; 
secure, clean and efficient energy; climate action, 
 environment, resource efficiency and raw materials; 
and Europe in a changing world — inclusive, innovative 
and reflective societies. 
Current EU research programmes highlight the 
need to go beyond rigid thematic approaches and 
are designed to increase collaboration across the 
research landscape to the benefit of society. The 
Lund Declaration adopted in 200929 and updated in 
201530 stresses how meeting the grand challenges 
in Europe would require a strengthening of the 
frontier research, and by Europe taking a global lead 
in the development of enabling technologies (such 
as biotechnology, information technology, materials 
and nano-technologies). It also highlights measures 
designed to support business development and public 
policy goals; the creation and maintenance of world-
class research infrastructures; and a risk-tolerant 
and trust-based approach in research funding.


THEM ATIC  
A REAS OF 
THE ER A-MBT 
ROA DM A P
“Marine biotechnology can unlock the pharmaceutical 
potential of marine origin materials leading to new 
treatment options.”
F E R NA N D O DE L A C A L L E  — H E A D OF M A R I N E M IC ROBIOLOGY R&D
PH A R M A M A R S A
CHAPTER 02
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INTRODUCTION
The Earth’s seas and oceans are largely underutilised 
and many gaps exist in our understanding of the 
potential of these marine territories as a future 
source of novel materials, as a source of safe, healthy 
food and of their contribution to the wellbeing of 
the planet. 
In line with the broad thrust of Horizon 2020, 
the ERA-MBT research and innovation roadmap 
highlights research areas that span scientific, 
technological, economic and societal challenges, 
and in doing so, sets a marine biotechnology research 
and innovation agenda to 2030. The five thematic 
areas of the roadmap are illustrated in Figure 2 
and described below.
Enabling technologies and infrastructure are central 
to and have an influential role in the activities of 
other thematic areas. Together they enable the 
exploration of the marine environment; support 
biomass production and processing; and contribute 
to product innovation. Their further development 
relies extensively on policy support and stimulation 
measures, as do the other thematic areas of the 
roadmap. The extent to which product innovation 
and differentiation activities are successful are likely 
to influence future policy support and stimulation 
initiatives. 
FIGURE 2  The five thematic areas of the strategic research and innovation roadmap
“Marine biotechnology is well 
positioned to contribute new 
knowledge and approaches 
in respect of managing the 
 marine environment and the 
sustainable exploitation of 
 marine organisms.”
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The core of each thematic area is the generation 
of knowledge to support product and process 
innovations, leading to the creation of sustainable 
research networks. There are also elements within 
themes that enable an expansion of marine 
biotechnology research and innovation. Each 
thematic area is built on the vision of marine 
biotechnology as an enabling technology. A 
technology that is cross-cutting and capable of 
contributing to the development of Europe’s plans 
for a knowledge-intensive bioeconomy; able to tackle 
societal challenges; and encourage a collaborative 
approach in creating industrial leadership. The 
fundamental principles in developing the bioeconomy 
are sustainability and minimising the generation 
of waste. Marine biotechnology is well positioned 
to contribute new knowledge and approaches in 
respect of managing the marine environment and 
the sustainable exploitation of marine organisms.
EXPLORATION OF THE  
MARINE ENVIRONMENT
Exploring the chemical and biological diversity 
of our oceans as a source of novel materials and 
food is the essence of this strategic research area. 
Against a backdrop of successful food, health and 
material innovations based on marine organisms, 
considerable optimism surrounds the future role 
of marine bioresources to contribute to Europe’s 
plans to expand the bioeconomy. 
Despite the promise of the oceans, the technical 
challenges of accessing areas outside the shallow 
coastal zone, and the costs of deepwater exploration, 
mean much of the oceans’ depths remain to be 
discovered. However, even in the absence of a 
significant pipeline of new organisms to screen 
for novel compounds, marine environments 
already provide materials used in the production 
of industrial chemicals, pharmaceuticals, food and 
food ingredients. 
Exploration and discovery activities are not limited 
to remote ocean areas and deep-waters. Europe’s 
extensive coastal regions are home to many 
species of microbes, algae, fish, crustaceans and 
invertebrates, all of which offer ease of access to 
marine bioresources for discovery type research.
“Marine exploration is largely 
dependent on collaborative 
r e s e a r c h  a c t i v i t y  a n d 
t e c h n o l o g i e s  d eve l o p e d 
outside the biological area.”
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Materials discarded during harvesting, cultivation 
and processing of marine species are used as human 
and animal food ingredients, fertilisers, nutritional 
supplements, biochemicals, proteins and lipids. 
Further exploration and examination of known 
sources of bioproducts is needed to expand the 
possible range of applications for such materials.
Marine exploration is largely dependent on 
collaborative research activity and technologies 
developed outside the biological area. The 
development of devices such as remotely operated 
vehicles allow for the collection of samples; data 
mining techniques can help to target areas of 
high marine biodiversity; remote sensing and 
geoinformatics provide insights to seabed structures 
and habitats, and metagenomics allows DNA to 
be recovered from microorganisms that cannot be 
cultured in the laboratory. The development of these 
new tools and methods is behind the renewed focus 
on marine exploration and bioprospecting. Using an 
array of modern analytical approaches it is possible 
to explore and characterise chemical compounds 
from within marine organisms as potentially useful 
products. Expanding the exploration of marine 
environments, some of which had previously 
remained out of reach, will provide researchers 
and industry with greater access to novel marine 
organisms thus enlarging the discovery pipeline. 
Future exploration activities can be built on 
capabilities and networks developed in EU research 
programmes and those evolving within Horizon 
2020. A major exploration opportunity for European 
marine biotechnology is to increase the rate of 
discovery of new organisms and build the RTDI 
capacity to utilise their potential. The roadmap 
identifies opportunities for,
• Continued targeting of microorganisms in 
deep-sea sediments, microbial symbionts from 
sponges and other organisms; macro- and 
micro-algae; bivalves, crustaceans, fish and 
fish processing discards, and marine fungi as 
sources of biologically active natural products;
• The discovery of new marine species including 
microorganisms, as a source of novel materials;
• Exploiting the potential of genetic resources in 
the discovery process; and 
• Exploring the chemical and biological diversity 
of marine organisms.
“Two main sources of marine 
biomass are wild and cultured 
species.”
19
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BIOMASS PRODUCTION  
AND PROCESSING
Europe’s plans to develop a bioeconomy are largely 
driven by knowledge of increases in global population, 
shrinking resources, increasing environmental 
pressures and climate change. In recognising the 
need for Europe to bring about changes in how 
biological resources are used, the bioeconomy 
strategy opens the way for Europe to adopt new 
approaches to managing its bioresources. In planning 
to create a resilient and resource efficient society, 
Europe recognises the need to overcome specific 
challenges in the sustainable production and use 
of biomass. Achieving sustainability in primary 
production and processing is fundamental to the 
creation of new products and to the future of the 
bioeconomy. Though presently a minor source of 
biomass, the potential of marine bioresources to 
meet these twin challenges is widely acknowledged. 
Two main sources of marine biomass are wild 
and cultured species. Securing sustainable marine 
biomass presents challenges, particularly if the sole 
source is from wild stocks, where overexploitation can 
threaten marine biodiversity, as well as ecosystem 
functions and services. Consistency, security and 
quality of biomass supply have to be balanced in 
ways that address environmental challenges. The 
well-managed and controlled culture of marine 
biomass, whilst similarly facing production challenges 
and being limited to certain species, needs to be 
further developed as sustainable sources of biomass 
in parallel with the development of sustainable 
harvesting of marine species from the wild. 
Creating useable products from marine biomass 
requires feedstock to undergo some form of 
transformation. Typically this is a refining or 
extraction process, which yields intermediate or 
final products. Biomass processing generally involves 
several intermediary steps from harvesting to end-
use. Long-term goals to improve the biorefining 
process include shortening the supply chain by 
integrating the cultivation and processing stages; 
optimising the production of customised feedstock; 
employing multi-stream bio-refining techniques; 
and creating circular sustainable supply chains — 
where products and materials flow in loops, assets 
are fully utilised and in which waste is eliminated.
There are also calls for flexible biomass 
transformation processes, where multiple sources 
of marine biomass can be refined into specific 
fractions. Technological advances may allow the use 
of biological resources to create biomass, leading to 
marine micro-organisms possibly becoming future 
bioprocessing “factories”. 
Key elements of the marine biotechnology production 
and processing roadmap include:
• Increasing the production of biomass from 
sustainable marine resources, including exploring 
the potential to develop on land, offshore and 
deep-water aquaculture. 
• Establishing the controlled culture of marine 
biomass at sea and on land, and developing 
techniques to culture marine organisms not 
currently in culture.
• Creating efficient transformation and refining 
processes, including concepts of multi-stream 
inputs and the refining of mixed biomass 
 feedstock.
“The health sector, which 
targeted marine-derived 
m o l e c u l e s  a s  n e w 
p h a r m a c e u t i c a l  e n t i t i e s , 
continues to emphasise the 
potential of marine  biomass 
in drug discovery”
20
• Reducing the complexity of the supply chain by 
integrating biomass production and refining, 
reducing energy demand and waste in processing 
marine biomass.
• Removing bottlenecks in marine biomass 
transformation and conversion by identifying 
novel processes and marine enzymes that can 
modify biomass, tailor its chemical and biological 
properties and reduce the energy demand of 
transformation. 
• Engaging in research to support the expansion of 
cultured biomass production including measures 
to minimise and mitigate environmental 
impacts; addressing waste management; 
enhance biosecurity and the introduction of 
new production systems (breeding/hatchery/
genetics/nutrition and health etc.) and expand 
the use of molecular methods.
• Harnessing knowledge and expertise from other 
sectors of the bioeconomy to support the rapid 
development of pilot scale equipment and scale-
up of marine biomass refining.
PRODUCT INNOVATION  
AND DIFFERENTIATION
Only a small fraction of marine biomass is presently 
used outside the food and feed sectors. Emerging 
market opportunities and completely novel 
applications for marine-derived compounds exist. 
The health sector, which targeted marine-derived 
molecules as new pharmaceutical entities, continues 
to emphasise the potential of marine biomass in 
drug discovery; filling gaps that more traditional 
sources of small molecules have not been able to fill. 
In the search for new biocompatible materials, the 
marine is home to a myriad of biological materials 
of interest to the engineering and medical devices 
sectors. 
Though attention is often directed to the creation 
of new products from novel marine materials, 
more accessible marine origin materials should 
not be overlooked. With the projected increases in 
aquaculture output, greater levels of fish landings 
at European ports, and changes in the Common 
Fisheries Policy, fish processing activities are set 
to increase. Whilst processors aim to maximise the 
recovery of the edible portion of fish, inevitably, 
not all materials are fully used. Termed “rest-raw 
materials” or “co-products”, this marine biomass 
is a rich source of polysaccharides, lipids, proteins, 
pigments, flavours, polymers and other chemical 
compounds all of which have product and process 
applications. Target markets for these materials 
“Establishing a link between 
researchers and the array 
of end-users is essential in 
stimulating innovation.”
21
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include human and animal nutrition, industrial 
chemicals, cosmetics, pharmaceuticals, personal 
care and food ingredients. Collagen and gelatine 
extracted from fish, and alginates, carrageenan and 
agars from algae, are widely used by the food sector. 
Not only is marine biomass proving to be the source 
of new product applications; considerable scope 
also exists for it to contribute new processing 
methods. The extensive marine biodiversity is an 
excellent source of novel biocatalysts. Initially 
pioneered by the foods sector, marine-derived 
enzymes have attracted the attention of the 
chemical, pharmaceutical, cosmetics, agriculture 
and environmental sectors, and can support an 
expansion of industrial bioprocessing. 
The interest of the agriculture and horticulture 
sector in marine materials is increasing as a result 
of evidence pointing to the beneficial effect of 
algal extracts in animal and plant health. Similar 
interests exist in the aquaculture sector, where there 
is an increased demand for alternative feedstock 
to replace traditional fishmeal both for nutritional 
and health benefits. 
Some seaweeds have a high capacity for nutrient 
absorption, making them attractive in multi-
trophic aquaculture where the waste products 
from one species contribute to the growth of 
another. However, they accumulate heavy metals 
and other pollutants, which could limit options 
to use them for animal and human applications. 
Significant scope exists to build upon, and add to 
the knowledge base of marine origin materials by 
supporting actions to: 
• Assess, profile, and maximise the sustainable 
use of marine bioresources for applications in 
human and animal food, as food ingredients, 
therapeutic compounds, medical devices and 
biomaterials, cosmetics and cosmeceuticals 
and as novel industrial materials and processes.
• Further isolate and analyse materials from marine 
biomass to enhance the understanding of their 
structures and modes of action in human and 
animal health and food/feed related areas.
• Create novel biosensors based on marine-derived 
materials or marine organisms and explore 
their use in monitoring environmental status 
and food safety.
• Assess the potential of marine origin materials to 
contribute to improved aquaculture performance 
including addressing health and disease issues 
within cultured populations, disease resistance 
and minimising environmental impacts of 
production.
• Investigate the inherent biocompatibility of some 
marine materials and assess their potential for 
use in medical devices, for drug delivery or in the 
repair, replacement or regeneration of tissue.
• Harness the potential of marine organisms to 
act as experimental models in health-related 
research.
ENABLING TECHNOLOGIES  
AND INFRASTRUCTURE
European marine biotechnology activity has made 
significant progress over the past decade in building 
a research community and infrastructure to support 
research and innovation. Despite this progress, there 
remains an acute need to continue to build research 
and innovation capacity — in both the research and 
enterprise sectors and to enhance the science and 
technology research infrastructure.
“Innovative policy direction can 
stimulate interaction between 
research and industry.”
22
Many of the tools and techniques employed in marine 
biotechnology are used in other areas of science 
and technology. Engaging in collaborative multi-
disciplinary research projects is one way of providing 
access to these facilities. Establishing a link between 
researchers and the array of end-users is essential 
in stimulating innovation. Expectations about 
enhancing the available research infrastructure 
to support product and process innovations have 
to be met; so too must access to essential core 
infrastructure. Such infrastructures include research 
vessels, exploration platforms, laboratories, pilot 
plant, databases and repositories and an array 
of increasingly complex analytical tools. Opening 
up, expanding and creating new infrastructure 
will broaden marine biotechnology research and 
innovation activity, attract industry collaborations, 
and deliver knowledge to support product and 
process development. 
Though there are strong links between the marine 
biotechnology research community and areas of 
fundamental and applied sciences, the need for 
dedicated research tools and facilities to fully exploit 
marine biological resources remains. Without advances 
in technologies that allow the discovery and mapping of 
the oceans depths, provide insights to new species, or 
provide for a greater understanding of the genetic and 
chemical diversity of marine bioresources, the impact 
of marine biotechnology on socio-economic progress 
could be limited. Future developments in the “omics” 
based approaches and single cell technologies; together 
with the development of novel heterologous expression 
systems will be key in this respect. These methods and 
advances in chemical/biochemical analysis will enhance 
our understanding of the composition, structure and 
function of marine organisms, thereby increasing our 
ability to identify opportunities to use the diversity of 
marine species as the basis for bio-based products.
Opportunities exist to bring new expertise and to 
build interaction between disciplines to support 
marine biotechnology, particularly leveraging the 
benefits from the involvement of information 
technology specialists and bioinformatics expertise. 
Marine biotechnology research is largely reliant 
on contributions from across the scientific and 
technological horizon to provide the all-essential 
“toolkit” necessary to explore marine environments 
and develop new products. Through measures that 
encourage the convergence of different disciplines, 
technologies and industry sectors, it will be possible 
to strengthen marine biotechnology research and 
innovation. Building lasting supportive infrastructures 
requires research to:
• Develop alternatives to the traditional collection 
or harvesting of marine organisms, including 
the development of methods to allow in-situ 
assessment and screening of marine organisms 
to increase the rate of the discovery of novel 
materials.
• Create predictive tools to improve the 
identification and targeting of biological “hot-
spots” in the oceans; including the use of “omics” 
based technologies.
• Identify and build new competencies and 
networks to support marine biotechnology 
research and innovation, e.g. applied 
bioinformatics.
• Develop automated equipment for use in habitat 
mapping, biological resource assessment and 
sample collection.
• Reduce the costs associated with discovery-
related activities.
• Create pilot facilities to support scale-up 
activities.
• Provide shared and open access marine data 
and biological repositories.
23
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POLICY SUPPORT AND STIMUL ATION
The ubiquitous nature of marine biotechnology results 
in research and innovation activities being shaped by 
a wide range of European and international policy 
instruments and regulations. Policy links to marine 
biotechnology include areas such as environment, 
fisheries and aquaculture, food, health, natural 
resources and industrial policy. Research activities 
can generate knowledge to inform policy, which in 
turn stimulates innovation.
Innovative policy direction can stimulate interaction 
between research and industry. The importance 
of such collaboration is crucial in enabling marine 
biotechnology-based innovation. New policy 
initiatives backed up by operational support can 
broaden the scope, performance and impact of 
marine biotechnology. 
Knowledge derived from marine biotechnology 
research informs how the marine environment 
can be managed sustainably and fulfil its role in 
providing environmental services to the planet. 
It can contribute to ocean governance and to the 
development of regulations concerning the use of 
ocean resources. Information secured from the 
marine environment informs decision-making in the 
public and private sectors. Marine biotechnology 
research has a lasting role in informing policy and 
decision-making in the public and private sectors. 
International conventions and treaties seek to 
establish principles and legal frameworks for 
managing ocean resources. For example, the United 
Nations Convention on Biological Diversity31 and, 
Convention on the Law of the Sea (UNCLOS)32, 
and the Nagoya Protocol on Access to Genetic 
Resources33 can influence how future marine 
biotechnology research develops. 
The evolution of international and European marine 
policy offers marine biotechnology researchers 
and industry with a wealth of new opportunities. 
Increased monitoring of the marine environment, 
biomass stock assessment, harmful algal blooms 
etc., requires new assessment tools to be developed. 
Data, samples and other material collected during 
exploration voyages need to be deposited in marine 
biobanks/repositories. Over time, these data can 
provide baseline information to inform policy 
concerning environmental status as well as be 
used in profiling marine biodiversity.
The marine bioresources policy arena is not totally 
reliant on scientific and technological knowledge; 
other research areas such as socio-economic, 
environmental and international law also inform 
how marine biotechnology might develop. Further 
policy opportunities exist as outlined below to:
• Identify ways to expand access to marine 
bioresources for discovery purposes in European 
waters and in the high seas
• Develop a comprehensive, planned policy research 
programme to apply the knowledge gained from 
marine biotechnology research to inform public 
policy, governance and regulation of marine 
environment and marine-derived products
• Support the introduction of common regulations 
across member states regarding the harvesting, 
culture and exploitation of marine biomass
• Establish efficient and responsive regulation and 
policy development relating to marine bioresources
• Identify mechanisms to attract greater industry 
participation in marine biotechnology related 
research
• Identify policy developments to advance marine 
biomass production and processing capabilities 
and to reduce barriers to the development of 
new markets for marine-derived products 
2 4
CONNECTING THE THEMATIC AREAS
Each thematic area is interlinked as shown in 
Figure 3. They form a chain of activity connecting 
policy, available tools and infrastructures, to 
research and the commercialisation of outputs. The 
whole chain is dependent on industry involvement, 
public and private funding and the formation of 
partnerships between researchers and enterprise, 
coupled with strong policy direction and support.


ROA DM A P FOR 
SHORT- A ND 
LONG-TERM 
ACTIONS
“Marine biodiversity constitutes a great source for 
novel ingredients and new components for the food 
and feed industry.”
T OR MOD T HOMSE N  — DI R EC TOR GLOB A L C AT EG ORY SE A FOOD, F I R M EN IC H S . A .
CHAPTER 03
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The Strategic Roadmap does not predict what will 
happen but rather indicates how, based on extensive 
interaction with stakeholders, marine biotechnology 
can develop the sustainable use of marine resources 
for new products and processes. 
Research topics in each thematic area are positioned 
as short-term (2016 to 2020) or long-term (2020 
to 2030) investment opportunities likely to provide 
economic and/or societal returns. 
Short-term actions resolve known problems and 
target the so-called “low-hanging fruits”, whereas 
long-term actions involve significant scientific, 
technological or other challenges.
EXPLORATION OF THE  
MARINE ENVIRONMENT
This thematic area comprises three interconnected 
sub-themes, on which the exploration of the marine 
environment and the discovery of novel materials 
depend — accessing marine habitats; targeting 
sources of marine biomass; and characterising 
marine organisms, including their chemical and 
biological composition.
Macro-algae and fish are the main sources of 
marine biomass currently used in commercial 
applications, principally as food and food ingredients. 
The results of various bioprospecting and discovery 
activities illustrate the possibilities for a wider 
range of applications for compounds derived from 
marine organisms. Marine organisms from extreme 
environments are targeted in the search for specific 
components for use as pharmaceuticals, enzymes 
and fine chemicals. 
Discards and residues from fish processing are 
important and available sources of biomass that 
are readily transformed by marine biotechnology. 
FIGURE 4  Exploration of the marine environment
SHORT-TERM (2016–2020)SUB-THEME
TARGET 
 SOURCES 
OF MARINE 
 ORGANISMS/ 
BIOMASS
ACCESS 
MARINE 
 HABITATS
 IDENTIFY 
 MARINE 
 SPECIES AND 
 CHARACTERISE 
 MATERIALS
LONG-TERM (2020–2030)
ALGAE, FISH, INVERTEBRATES AND MICROORGANISMS
USE OF RVs AND ROVs  TO COLLECT SAMPLES
TRADITIONAL AND NOVEL TAXONOMIC APPROACHES
MOLECULAR BASED METHODS
CHEMICAL AND BIOCHEMICAL ANALYSIS OF MATERIALS 
DISCARDS AND PROCESSING RESIDUES
ORGANISMS FROM EXTREME ENVIRONMENTS AND AND  BIODIVERSITY HOT-SPOTS
USE AUV TO ACCESS  AND COLLECT AND SAMPLES
COLLABORATE AND SHARED ACCESS TO EU RVs
REMOTE SYSTEMS FOR IN-SITU ANALYSIS
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Europe’s reformed common fisheries policy places 
a new emphasis on extracting value from the 
catch. Similarly, though at a much smaller scale 
in Europe, seaweeds (macro-algae) are also being 
processed, having long been identified as sources 
of polysaccharides, minerals and other nutrients, 
whilst micro-algae have emerged as an important 
source of lipids. The utilisation of such biomass is 
likely to become well established in the long term. 
There is a vast array of samples from marine 
organisms in repositories, though few countries 
maintain national repositories or biobanks for marine 
materials. This immediate research opportunity to 
explore and profile these samples is likely to be a 
long-lasting research challenge, set to benefit from 
new analysis and screening techniques.  The  collection 
of new samples from targeted marine areas will 
gradually add materials to existing repositories. 
Technological developments such as molecular 
systematics are likely to support novel approaches to 
taxonomy, strengthen the understanding of marine 
organisms and increase the capacity to explore the 
accumulated samples.
Accessing remote marine environments will be 
supported by technological developments. Already 
the collection of marine samples from deep waters 
is a task performed by remotely operated vehicles 
(ROVs). The introduction of more advanced sampling 
and identification techniques will accelerate the 
exploration process. New generations of autonomous 
under-water vehicles (AUVs) to access and collect 
samples may be combined with remote systems 
for in-situ analysis, adding additional capacity to 
support long-term research and enabling more 
rapid screening of marine compounds. 
BIOMASS PRODUCTION  
AND PROCESSING
The challenge of sustainability is highlighted as a 
major component within this thematic area. Research 
and innovation sub-themes comprise the capture and 
use of wild species, the cultivation of marine species 
and the subsequent transformation or refining of 
marine biomass. The capture of wild species as an 
input to bioprocessing has to be sustainable and 
achieved without creating adverse impacts on the 
marine ecosystem.
The capture of wild species as an input to 
bioprocessing has to be sustainable and achieved 
without creating adverse impacts on the marine 
ecosystem. The bulk of the wild harvested species 
comprises fish, crustaceans and macro-algae. In the 
short term, a more selective targeting of species 
including, where feasible, the sustainable harvesting 
of macro-algae is required. In the long-term, species 
considered as “invasive species” and entirely new 
species identified during bioprospecting, may become 
valuable sources of useful biomass. 
The culture of marine organisms is confined 
to the production of finfish, shellfish and to a 
lesser extent algae (macro-algae) in near-shore 
aquaculture activities. Some species of micro-algae 
are established as a recognised source of lipids and 
other high value products (e.g. pigments) and are 
cultured in land-based bioreactors. It is expected 
that these activities will continue with production 
levels increased and expanded to include new species 
and new culturing regimes where this is possible. 
Offshore and deep water aquaculture and integrated 
multi-trophic aquaculture (IMTA) are active research 
topics. Changes in culturing processes are likely to 
expand the use of cultured biomass from food to 
include non-food use as well as develop new sources 
of feed. Marine biotechnology, including new breeding 
and genomics, is set to support more diverse and 
productive culturing of marine organisms. This 
optimised approach is a long-term opportunity 
that could open the way for the production of 
specific high-value compounds from selected species. 
The conversion of marine biomass, whether from 
wild or cultured sources into useful fractions capable 
of supporting an array of product applications, is a 
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transformation process. Such processes, including 
bio-processing, should be sustainable, minimise 
waste, be energy efficient and carbon neutral, and 
operate without any negative environmental impact. 
In the short-term, these requirements will result in 
a move from single-stream refining towards multi-
stream biorefining, to become fully embedded in 
new biorefining processes. Long-term activities 
include the development of processes that allow 
the integration of the production and processing 
of marine biomass and the creation of biorefineries 
capable of processing of mixed/multiple feedstock. 
PRODUCT INNOVATION  
AND DIFFERENTIATION
Human and animal health products, food and feed 
products, industrial products and processes, and 
environmental measures are sub-themes within this 
thematic area. The two first sub-themes focus on the 
development of nutrition and healthcare products 
for human and animal markets. Food, feedstock 
and other agri-products, nutritional supplements, 
nutraceuticals, functional foods and cosmetics will 
remain research targets. The sub-themes also include 
products that offer longer-term opportunities such 
as pharmaceuticals, therapeutics and biocompatible 
materials. Developing new pharmaceuticals and 
other medical applications is typically a lengthy and 
highly regulated process that is known to take up to 
FIGURE 5  Biomass production and processing
SHORT-TERM (2016–2020)SUB-THEME
SUSTAINABLE 
USE OF WILD 
SPECIES
SUSTAINABLE 
CULTURE 
OF MARINE 
 ORGANISMS
TRANSFORMA-
TION/REFINING 
MARINE BIOMASS
LONG-TERM (2020–2030)
FISH, ALGAE AND OTHER SPECIES
CULTURED MICRO ALGAE 
NEAR SHORE AQUACULTURE OF FISH AND ALGAE
SINGLE STREAM REFINING
INTEGRATED PROCESSING OF MIXED FEED-STOCK
SUSTAINABLE HARVESTING OF ALGAE
NEW SPECIES IDENTIFIED
INVASIVE SPECIES
OFF-SHORE AQUACULTURE
MULTI-STREAM REFINING OF MIXED FEED-STOCK
LAND BASED AQUACULTURE
IMTA
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30 years from discovery to final product approval. 
Technological advances will have a strong influence on 
the extent to which it may be possible to reduce time 
to market for marine origin health products. Human 
and animal wellbeing, including the development of 
customised diets follow-on from marine-derived 
prebiotic and probiotic products and identified 
as offering long-term potential. Maintaining the 
health of animals used in the human food chain is 
a global priority and hence is identified as a long-
term activity. 
Marine compounds are already used in cosmetic and 
cosmeceutical products. Identified as an expanding 
global market, opportunities for greater use of 
marine compounds in these products exist and as 
such span short- and long-term horizons of the 
roadmap. 
FIGURE 6  Product innovation and differentiation
SHORT-TERM (2016–2020)SUB-THEME
HUMAN AND 
ANIMAL HEALTH 
PRODUCTS
FOOD AND  
FEED PRODUCTS
NEW  INDUSTRIAL 
PRODUCTS AND 
PROCESSES
ENVIRONMEN-
TAL MEASURES
LONG-TERM (2020–2030)
NUTRITIONAL SUPPLEMENTS
MARINE BIORESOURCES FOR FOOD
FOOD SAFETY AND QUALITY
TECHNO-FUNCTIONAL INGREDIENTS
FUNCTIONAL FOODS AND NUTRACEUTICALS
COSMETICS AND COSMECEUTICALS
PREBIOTICS AND PROBIOTICS
PHARMACEUTICALS
FINE CHEMICALS/ENZYMES/BIOMATERIALS
BIOLOGICAL INDICATORS AND SENSORS
BIOREMEDIATION AND OCEAN HEALTH
CUSTOMISED DIETS
INTEGRATED FEED/FOOD PRODUCTION 
BIOCOMPATIBLE MATERIALS
SYNTHETIC BIOLOGY/BIOSYNTHESIS
NEW SPECIES FOR FOOD
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The search for new food and feed products is 
expected to continue in response to projections of 
increased global populations and the associated 
demand for new protein sources. The capacity of 
the marine area to support these areas is likely 
to be challenged unless new sustainable feed to 
support aquaculture and species diversification is 
developed. An integration or combination of food 
and therapeutics is seen as a long-term target; 
strongly connected to the increased use of marine 
compounds in functional foods and ingredients. 
Exploiting the physical-chemical properties of marine 
compounds such as gelling agents, pigments and 
fibre derived from algae, and collagen from fish is 
set to continue. New approaches to support long-
term marine foods production include shortening 
the supply chain by integrated feed/food production 
systems. 
New concepts of biorefining marine biomass 
will enable the development of fine chemicals, 
enzymes and biomaterials. The short-term focus is 
on applications that enhance food safety and quality, 
whilst longer-term targets include customised 
products based on optimised bioprocessing. Scope 
also exists to maximise the potential of synthetic 
biology to contribute to the development of novel 
marine biological systems and processes.
The known potential of marine biotechnology to 
contribute to the development of sensors and 
biological indicators is a lasting opportunity. 
Using marine organisms, or derived products and 
processes for bioremediation are important long-
term opportunities closely linked to efforts to 
improve interactions between human activities and 
the oceans in general. 
ENABLING TECHNOLOGIES  
AND INFRASTRUCTURE
The availability of a relevant and accessible research 
infrastructure comprising physical and human 
resources and capabilities is essential to continue the 
development and utilisation of outputs from marine 
biotechnology. Though scientific and technological 
developments have evolved to explore marine 
environments, the need to enhance the array of 
physical, chemical and genetic analytical tools, 
on which marine biotechnology relies, remains. 
Increasingly, marine biotechnology relies on 
scientific and technological developments from 
other disciplines. The provision of new and improved 
infrastructures can lead to the creation of new 
scientific expertise, stimulate research activity and 
facilitate greater collaboration. 
Providing marine biotechnology with access to 
enabling technologies and infrastructures is 
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underpinned by activities within three connected 
sub-themes — research and innovation networks; the 
development of tools and methods; and providing 
the supporting infrastructure. 
At the core of these sub-themes is the development 
of the suite of analytical tools and methodologies 
to explore and characterise marine organisms. 
Some “tools” exist , and already support 
marine biotechnology, whilst others are yet to 
be fully utilised or customised for specific use. 
The ERA-MBT survey of research infrastructure 
identified opportunities to improve the research 
environment by providing better access and 
strengthening collaboration. In the short-term, 
there is a focus on building national and industry 
networks, clusters and public-private partnerships 
such that they become a foundation for long-
FIGURE 7  Enabling technologies and infrastructure
SHORT-TERM (2016–2020)SUB-THEME
R&I NETWORKS 
AND COLLABO-
RATION
DEVELOPMENT 
OF THE MARINE 
BIOTECH TOOL-
BOX
SUPPORTING  
INFRASTRUCTURE
LONG-TERM (2020–2030)
NATIONAL NETWORKS
PROJECTS
EU RESEARCH NETWORKS
EU RESEARCH PROGRAMMES
MODEL ORGANISMS
HABITAT AND SEABED MAPPING 
DEEP-SEA COLLECTION VIA RV WITH ROVs
PREDICTIVE TOOLS TO LOCATE BIOLOGICAL ”HOT-SPOTS”
AUTONOMOUS RESEARCH VESSELS AND COLLECTION SYSTEMS
OMICS BASED TECHNOLOGIES
BIOINFORMATICS
NOVEL CHEMICAL AND BIOCHEMICAL ANALYSIS/CHARACTERISATION 
INDUSTRY NETWORKS/CLUSTERS/PPPs
SELF-SUSTAINING RTDI NETWORKS
INTEGRATE EXPERTISE FROM UNCONNECTED AREAS OF S&T
IN-SITU ANALYSIS AND SCREENING
PILOT FACILITIES FOR SCALE-UP
DATA AND BIOLOGICAL REPOSITORIES
MARINE BIORESOURCES KNOWLEDGE PORTAL
ACTIVITY INVOLVING RELATED INTERDISCIPLINARY AREAS INCREASED 
HETEROLOGOUS AND SINGLE CELL
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term improvements. These include the creation of 
self-sustained marine biotechnology research and 
innovation networks that are closely associated 
with and facilitate the integration of expertise 
from currently unconnected areas of enabling 
technologies. 
A major opportunity to enhance the marine 
biotechnology toolbox is by the widespread adoption 
of rapid screening and " –omics" technologies. This 
will increase the capacity to explore and characterise 
marine organisms and compounds. Though there are 
examples where these tools are used, a long-term 
challenge is to expand their use. New developments 
including in-situ analysis and screening, heterologous 
single cell approaches and biosynthesis are long-
term priorities. Current interest in model organisms 
and novel bioassays from marine organisms is likely 
to remain. 
In parallel with the development of the “toolbox”, 
there is a need to continue to provide physical 
infrastructures. Some of these such as pilot facilities 
to scale-up from laboratory scale are process 
oriented, whilst further development of sample 
collection systems, and making data from biological 
repositories more widely available are discovery 
related, however, all require long-term support.
Existing habitat mapping of marine areas is set 
to continue and be expanded in the long term to 
include all Europe’s marine territories. This knowledge 
will support the development of predictive tools 
designed to identify marine biological “hotspots”. 
Meeting this long-term challenge will improve the 
efficiency of sampling, as will the development of 
autonomous research vessels. 
A lasting challenge is the dissemination of knowledge 
about marine bioresources, research capabilities, 
equipment and facilities, all of which are essential 
in realising the benefits from increased marine 
biotechnology activities. The current and largely 
informal information and knowledge infrastructures 
could be developed into a dedicated marine 
bioresources/biotechnology knowledge portal. 
POLICY SUPPORT AND STIMUL ATION
This theme concerns policy issues relevant to the 
governance, regulation and stimulation of marine 
biotechnology activities. It is a theme that will draw 
from knowledge generated elsewhere and apply 
it to develop policy measures that support the 
role of marine biotechnology in exploiting marine 
bioresources. Research activities conducted across 
other thematic areas will inform policy and other 
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measures relating to the legal and environmental 
frameworks within which marine biotechnology 
operates. In addition, such research outputs will 
strengthen the use of marine biotechnology in 
driving economic and societal development. The 
strong emphasis of marine biotechnology research 
on the sustainability of marine environments and 
bioresources enhances the positive image of marine 
biotechnology. Policy decisions will influence decision-
making around funding and other initiatives designed 
to expand the contribution of marine biotechnology 
to Europe’s bioeconomy. 
With a projected expansion of exploration activity, 
the overarching legal issues concern access to and 
ownership of biological resources from marine areas. 
The Convention on Biological Diversity (CBD) and the 
Nagoya protocol – a supplementary agreement to 
the CBD, provides the basic framework for national 
and international agreements in this regard and are 
likely to continue to do so. Regulations concerning 
Access and Benefit Sharing (ABS) are likely to 
become relevant in parallel with the development 
of the marine bioeconomy. Despite the need for 
actions to protect and preserve marine biodiversity 
and ocean resources, the implementation of full 
ABS is set to remain a long-term activity, as are 
international agreements for ABNJ (Areas Beyond 
National Jurisdiction). 
Environmental regulations, including the introduction 
of common licensing systems for harvesting marine 
resources, are short-term priorities. Systems as these 
can be further enhanced by knowledge captured 
during the implementation of the Marine Strategy 
Framework Directive (MSFD), to become enablers 
of sustainable marine biotechnology activity. Marine 
spatial planning activities are also likely to influence 
marine biotechnology related activities, and open 
the way for new biotechnology driven opportunities. 
FIGURE 8  Policy support and stimulation
SHORT-TERM (2016–2020)SUB-THEME
LEGAL ISSUES
ENVIRONMENTAL 
 REGULATIONS
DEVELOP THE 
BIOECONOMY
LONG-TERM (2020–2030)
NATIONAL AGREEMENTS ON ACCESS
NATIONAL AND SOME EU AGREEMENTS
NATIONAL AND EU SUPPORTS FOR MBT 
COMMON LICENSING AND USE OF MARINE BIORESOURCES
DEDICATED FUNDING SCHEMES LED BY INDUSTRY
MARKET SUPPORTS TO DEVELOP MBT APPLICATIONS
FUNDING FOR OPEN INNOVATION INVOLVING MBT
VC FUNDS RECOGNITION OF MBT DEVELOPMENT
MBT VISIBLE IN RELEVANT FUNDING SCHEMES PPPs FOR MBT 
KNOWLEDGE-BASED REGULATION INFORMED BY MSFD AND SPATIAL PLANNING 
FULL ABS IMPLEMENTED
OPEN ACCESS TO KNOWLEDGE GLOBAL AGREEMENTS ON ACCESS
ABNJ
NAGOYA PROTOCOL
EU AGREEMENTS ON ACCESS TO MARINE BIORESOURCES 
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Marine biotechnology related activities benefit 
from direct and indirect national and EU support. 
However, new and more substantial initiatives 
are needed to accelerate the uptake and impact 
of marine biotechnology in Europe. Changes in 
existing funding initiatives could facilitate such 
developments. In building on increasing market 
success, support should be such that funding 
schemes respond to, and encourage new marine 
biotechnological developments, including the 
participation by industry in research projects. Such 
actions could provide venture capital funds with 
the confidence to recognise marine biotechnology 
as a central, enabling technology in the creation of 
high-potential, enduring investment areas based 
on the use of marine biological resources. Until 
marine biotechnology literacy has improved, this 
type of investment remains a long-term challenge. 
Other mechanisms to expand the role of marine 
biotechnology in the broader bioeconomy include 
funding to encourage open innovation and the 
creation of dedicated public-private partnerships 
(PPPs) where marine biotechnology is recognised 
as an enabler of  enterprise activity. 
THE WAY FORWARD FOR  
MARINE  BIOTECHNOLOGY —  
IMPLEMENTING THE ROADMAP 
ERA-MBT operates until the end of 2017 by which time 
it should give direction to the future development 
of marine biotechnology research and innovation. 
A major goal of ERA-MBT is to position marine 
biotechnology within a self-sustained enterprise 
driven network that is supported by national and 
European funding agencies. Reaching this goal 
delivers the vision for European Marine Biotechnology 
set by the ESF-Marine Board in its 2010 position 
paper34, that sought to create by 2020,
“… an organised, integrated and globally competitive 
European Marine Biotechnology sector that will 
apply, in a sustainable and ethical manner, advanced 
tools to provide a significant contribution towards 
addressing key societal challenges in the areas of food 
and energy security, development of novel drugs and 
treatments for human and animal health, industrial 
materials and processes and the sustainable use and 
management of the seas and oceans.”
The ERA-MBT roadmap identifies marine 
biotechnology as a key to the sustainable exploitation 
of marine biological resources. It offers new sources 
of materials, and as an emerging high-potential 
element of the bioeconomy is set to stimulate growth 
and create new jobs by exploiting the potential 
of marine biological resources in many different 
industry sectors.
As an emerging opportunity area, marine 
biotechnology supports the achievement of the 
objectives of Blue Growth35, the Bioeconomy Strategy 
for Sustainable Growth36 and hence contributes to 
Europe’s plans to develop a bioeconomy.
The ERA-MBT roadmap provides a framework 
for marine biotechnology related research and 
innovation activity up to 2030; it builds upon 
current knowledge and achievements and identifies 
future research and innovation opportunity areas. 
The holistic approach adopted in developing the 
roadmap ensures its relevance in supporting Europe’s 
long-terms commitment to addressing economic, 
environmental and societal challenges. 
The roadmap will be useful to national and European 
organisations in developing policy measures to 
address the challenges of each thematic area, and 
those funding agencies that provide supports to 
encourage marine biotechnology. Within the ERA-
MBT, the roadmap will inform “calls” for research 
proposals.
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THE ROADMAP PROCESS
This roadmap for marine biotechnology was 
developed by the ERA-MBT project between October 
2014 and March 2016. The aim of the process was 
to identify the research and innovation activities 
required to the year 2030.
Developing long-term plans typically involves 
A PPENDIX 1
obtaining contributions from wide stakeholder 
groups. The ERA-MBT employed four different 
approaches to secure creative, robust and relevant 
views concerning future marine biotechnology 
research and innovation as outlined below in Figure 9. 
The extensive desk study of marine biotechnology 
activities provided insights into the current status 
DESK STUDIES STAKEHOLDER  CONFERENCE
FORESIGHT  
STUDY
QUESTIONNAIRES 
AND INTERVIEWS
THEMATIC RESEARCH  
ARES IDENTIFIED
ROADMAP  
DEFINED
INTER NATIONAL ADVISORY  
GROUP REVIEW
FIGURE 9  Sources informing the development of the research roadmap
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of relevant and related RTDI activities. This review 
also took account of various national and European 
policies that had created the environment, within 
which marine biotechnology activities could develop. 
In addition, it identified a vast array of research 
and innovation programmes and projects targeting 
the discovery and exploitation of various forms of 
marine biomass. 
The ERA-MBT project stakeholder event in 2014 
yielded a broad consensus on future research 
opportunities, bottlenecks and actions required 
to continue to drive European marine biotechnology 
activities. In parallel, ERA-MBT launched an online 
survey for stakeholders to identify research needs 
and uncover factors that inhibit innovation. A  series 
of targeted telephone interviews with firms across 
EU member states validated the findings of the 
survey.
Finally, the ERA-MBT project conducted a foresight- 
type exercise, termed “OUTLOOK”. This exercise 
recruited a panel of 14 experts from various 
disciplines associated with marine biotechnology 
and challenged them to identify the most important 
factors influencing the future application and use 
of marine biotechnology. The OUTLOOK panel 
created possible future scenarios and proposed 
thematic research areas required to stimulate marine 
biotechnology product and process innovation. 
The roadmap developed by the ERA-MBT project and 
presented in this report results from the convergence 
and analysis of the various stakeholder contributions 
and expert opinions and identifies areas of marine 
biotechnology research required to maximise the 
contribution of marine bioresources to the European 
bioeconomy and help to address Europe’s grand 
societal challenges.
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ERA-MBT goals 
The objectives of ERA-MBT are to:
• St imulate  trans-European mar ine 
biotechnology research, innovation and 
enterprise activity.
• Build communities and capacity considering 
the maritime regions’ different perspectives 
and potential.
• Deliver a lasting network to fund and support 
marine biotechnology research and enterprise 
activity.
• Further increase the level of coordination 
between European research funding bodies 
in the area of marine biotechnology.
• Seek complementarities between national 
and international activities.
• Pool resources to undertake joint funding of 
trans-national RTDI projects.
• Increase the awareness of marine biotechnology 
as an enabler for value creation from marine 
biological resources.
MARINE BIOTECHNOLOGY ERA-NET 
(ERA-MBT ) 
About ERA-MBT
ERA-MBT brings together 19 partners from 14 
countries across Europe to work with stakeholders 
in identifying marine biotechnological needs and 
gaps in the value chain in an attempt to increase 
the valorisation of marine bioresources. The 
ERA-MBT project was launched in December 
2013 and will operate until the end of 2017. 
Marine biotechnology can create value from 
marine bioresources, however, to do so requires 
the current level of collaborative research in 
this area to expand. Measures that encourage 
expertise from the marine related biological 
and chemical sciences to work more closely 
with other areas of science and technology 
are necessary to achieve such collaboration. 
Research capacity, knowledge and resources, 
including research infrastructures, are needed to 
fully engage in marine biotechnology. To further 
develop marine biotechnology research and 
innovation capacity and capabilities, Europe 
should target efforts towards finding and 
exploiting competitive niches. The trans-European 
collaboration planned by ERA-MBT aims to build 
synergies and create greater value for the money 
through coordinated European funding and by 
prioritising research and innovation activity within 
this area.
A PPENDIX 2
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The ERA-MBT is designed to enhance the coordination 
of marine biotechnology related research funding 
programmes at international, national and 
regional levels. By building on the achievements 
of the Coordination and Support Action in Marine 
Biotechnology — CSA MarineBiotech, ERA-MBT aims 
to draw attention to new research and innovation 
opportunities and create new funding initiatives 
to direct research towards priority areas. ERA-
MBT will launch at least three transnational calls 
for research proposals; these will be informed by 
stakeholder feedback and the development of 
a strategic roadmap for marine biotechnology 
research and innovation.  
Achieving the broad goals of ERA-MBT requires a 
detailed understanding of the key drivers and other 
factors that will influence the future development 
of marine biotechnology. The ERA-MBT will initiate 
a series of actions to inform this understanding 
including,
• Performing various desk studies
• Hosting stakeholder events  
and undertaking surveys
• Completing a foresight exercise
• Developing a research and innovation roadmap
These activities contribute to the core elements of 
ERA-MBT, principally the initiation of joint calls for 
research in priority areas and laying the groundwork 
to build a sustainable network of funding agencies 
that are committed to continue developing marine 
biotechnology related research and innovation 
actions.
More details concerning the ERA-MBT are available 
at www.marinebiotech.eu.
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ABS   Access and Benefit Sharing
ABJN   Areas Beyond National Jurisdiction
AUV   Autonomous Underwater Vehicle
CSA   Coordination and Support Action
DNA   Deoxyribonucleic acid
EC   European Commission
ERA-MBT  Marine Biotechnology ERA-NET
ERA-NET  European Research Area Network
EU   European Union
IMTA   Integrated Multi-Trophic Aquaculture
MBT   Marine biotechnology
MSFD   Marine Strategy Framework Directive
OECD   Organisation for Economic Co-operation and Development
OUTLOOK  The ERA-MBT foresight process
PPP   Public–Private Partnership 
ROV   Remotely Operated Underwater Vehicle
RTDI   Research, Technological Development and Innovation
SME   Small and Medium-sized Enterprise
UNCLOS  United Nations Convention on the Law of the Sea
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The Marine Biotechnology ERA-NET is a consortium of 19 national funding bodies 
 representing 14 countries seeking complementarities between national activities and 
resources to undertake joint funding of transnational projects in the area of Marine 
Biotechnology.
Agentschap Innoveren en Ondernemen — VLAIO , Belgium 
Executive Agency for Higher Education, Research, Development and Innovation Funding — UE-
FISCDI , Romania 
Federal Ministry of Education and Research — BMBF , Germany 
Flanders Marine Institute — VLIZ , Belgium 
Foundation for Science and Technology — FCT , Portugal 
Icelandic Food and Biotech R&D Institute — MATIS OHF , Iceland 
Innovation Fund Denmark — IFD , Denmark 
Innovation Norway — IN , Norway 
Marine Institute — MI , Ireland 
Ministry of Education, Science and Sport — MIZS , Slovenia 
National Research Council — CNR , Italy 
New Caledonia Economic Development Agency — ADECAL , New Caledonia 
Region Västra Götaland — VGR , Sweden 
Research Centre Jülich — JÜLICH , Germany 
Spanish Ministry of Economy and Competitiveness — MINECO , Spain 
Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning 
— FORMAS , Sweden 
The Icelandic Centre for Research — RANNIS , Iceland 
The National Center for Scientific Research — CNRS , France 
The Research Council of Norway — RCN , Norway (Coordinator)
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